These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 12711614)
1. Endocannabinoids as mediators in the heart: a potential target for therapy of remodelling after myocardial infarction? Hiley CR; Ford WR Br J Pharmacol; 2003 Apr; 138(7):1183-4. PubMed ID: 12711614 [TBL] [Abstract][Full Text] [Related]
2. CB(1) cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction. Wagner JA; Hu K; Karcher J; Bauersachs J; Schäfer A; Laser M; Han H; Ertl G Br J Pharmacol; 2003 Apr; 138(7):1251-8. PubMed ID: 12711625 [TBL] [Abstract][Full Text] [Related]
3. Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. Wagner JA; Hu K; Bauersachs J; Karcher J; Wiesler M; Goparaju SK; Kunos G; Ertl G J Am Coll Cardiol; 2001 Dec; 38(7):2048-54. PubMed ID: 11738314 [TBL] [Abstract][Full Text] [Related]
4. Endocannabinoid overactivity and intestinal inflammation. Di Marzo V; Izzo AA Gut; 2006 Oct; 55(10):1373-6. PubMed ID: 16966693 [TBL] [Abstract][Full Text] [Related]
5. The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids. Pertwee RG AAPS J; 2005 Oct; 7(3):E625-54. PubMed ID: 16353941 [TBL] [Abstract][Full Text] [Related]
6. Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats. de Resende MM; Mill JG Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):274-9. PubMed ID: 17324137 [TBL] [Abstract][Full Text] [Related]
7. Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction. Solomon SD; Shin SH; Shah A; Skali H; Desai A; Kober L; Maggioni AP; Rouleau JL; Kelly RY; Hester A; McMurray JJ; Pfeffer MA; Eur Heart J; 2011 May; 32(10):1227-34. PubMed ID: 21317148 [TBL] [Abstract][Full Text] [Related]
8. Endogenous cannabinoids contribute to remote ischemic preconditioning via cannabinoid CB2 receptors in the rat heart. Hajrasouliha AR; Tavakoli S; Ghasemi M; Jabehdar-Maralani P; Sadeghipour H; Ebrahimi F; Dehpour AR Eur J Pharmacol; 2008 Jan; 579(1-3):246-52. PubMed ID: 17950273 [TBL] [Abstract][Full Text] [Related]
9. [Cardiac and vascular effects of cannabinoids: toward a therapeutic use?]. Ribuot C; Lamontagne D; Godin-Ribuot D Ann Cardiol Angeiol (Paris); 2005 Mar; 54(2):89-96. PubMed ID: 15828464 [TBL] [Abstract][Full Text] [Related]
10. [Functional role of the endocannabinoid system in emotional homeostasis]. Marco EM; Viveros MP Rev Neurol; 2009 Jan 1-15; 48(1):20-6. PubMed ID: 19145562 [TBL] [Abstract][Full Text] [Related]
11. Cannabinoid receptors and their ligands. Pertwee RG; Ross RA Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):101-21. PubMed ID: 12052030 [TBL] [Abstract][Full Text] [Related]
12. Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning. Pacher P; Haskó G Br J Pharmacol; 2008 Jan; 153(2):252-62. PubMed ID: 18026124 [TBL] [Abstract][Full Text] [Related]
13. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction. Huang BS; White RA; Ahmad M; Tan J; Jeng AY; Leenen FH Cardiovasc Res; 2009 Feb; 81(3):574-81. PubMed ID: 18689429 [TBL] [Abstract][Full Text] [Related]
14. Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarction. Koch M; Spillmann F; Dendorfer A; Westermann D; Altmann C; Sahabi M; Linthout SV; Bader M; Walther T; Schultheiss HP; Tschöpe C Eur J Pharmacol; 2006 Nov; 550(1-3):143-8. PubMed ID: 17022964 [TBL] [Abstract][Full Text] [Related]
15. Cannabinoids and haemostasis. Zakrzeska A; Grędziński T; Kisiel W; Chabielska E Postepy Hig Med Dosw (Online); 2016 Jul; 70(0):760-74. PubMed ID: 27383573 [TBL] [Abstract][Full Text] [Related]
16. Pretreatment with angiotensin receptor blockade prevents left ventricular dysfunction and blunts left ventricular remodeling associated with acute myocardial infarction. Thai H; Castellano L; Juneman E; Phan H; Do R; Gaballa MA; Goldman S Circulation; 2006 Oct; 114(18):1933-9. PubMed ID: 17060375 [TBL] [Abstract][Full Text] [Related]
17. Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction. Fraccarollo D; Widder JD; Galuppo P; Thum T; Tsikas D; Hoffmann M; Ruetten H; Ertl G; Bauersachs J Circulation; 2008 Aug; 118(8):818-27. PubMed ID: 18678774 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice. Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603 [TBL] [Abstract][Full Text] [Related]
19. Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions. Mendizábal VE; Adler-Graschinsky E Br J Pharmacol; 2007 Jun; 151(4):427-40. PubMed ID: 17450170 [TBL] [Abstract][Full Text] [Related]
20. In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability. Giuffrida A; McMahon LR Prostaglandins Other Lipid Mediat; 2010 Apr; 91(3-4):90-103. PubMed ID: 19523530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]